Structural and functional insights into the epigenetic regulator MRG15
© 2023. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society..
MORF4-related gene on chromosome 15 (MRG15), a chromatin remodeller, is evolutionally conserved and ubiquitously expressed in mammalian tissues and cells. MRG15 plays vital regulatory roles in DNA damage repair, cell proliferation and division, cellular senescence and apoptosis by regulating both gene activation and gene repression via associations with specific histone acetyltransferase and histone deacetylase complexes. Recently, MRG15 has also been shown to rhythmically regulate hepatic lipid metabolism and suppress carcinoma progression. The unique N-terminal chromodomain and C-terminal MRG domain in MRG15 synergistically regulate its interaction with different cofactors, affecting its functions in various cell types. Thus, how MRG15 elaborately regulates target gene expression and performs diverse functions in different cellular contexts is worth investigating. In this review, we provide an in-depth discussion of how MRG15 controls multiple physiological and pathological processes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Acta pharmacologica Sinica - 45(2024), 5 vom: 04. Apr., Seite 879-889 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jiang, Nan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cell proliferation |
---|
Anmerkungen: |
Date Completed 26.04.2024 Date Revised 28.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41401-023-01211-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36682516X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36682516X | ||
003 | DE-627 | ||
005 | 20240428231910.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41401-023-01211-6 |2 doi | |
028 | 5 | 2 | |a pubmed24n1391.xml |
035 | |a (DE-627)NLM36682516X | ||
035 | |a (NLM)38191914 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jiang, Nan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Structural and functional insights into the epigenetic regulator MRG15 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.04.2024 | ||
500 | |a Date Revised 28.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society. | ||
520 | |a MORF4-related gene on chromosome 15 (MRG15), a chromatin remodeller, is evolutionally conserved and ubiquitously expressed in mammalian tissues and cells. MRG15 plays vital regulatory roles in DNA damage repair, cell proliferation and division, cellular senescence and apoptosis by regulating both gene activation and gene repression via associations with specific histone acetyltransferase and histone deacetylase complexes. Recently, MRG15 has also been shown to rhythmically regulate hepatic lipid metabolism and suppress carcinoma progression. The unique N-terminal chromodomain and C-terminal MRG domain in MRG15 synergistically regulate its interaction with different cofactors, affecting its functions in various cell types. Thus, how MRG15 elaborately regulates target gene expression and performs diverse functions in different cellular contexts is worth investigating. In this review, we provide an in-depth discussion of how MRG15 controls multiple physiological and pathological processes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a DNA damage repair | |
650 | 4 | |a MRG15 | |
650 | 4 | |a cell proliferation | |
650 | 4 | |a chromatin remodelling | |
650 | 4 | |a epigenetic modifications | |
650 | 4 | |a senescence | |
700 | 1 | |a Li, Yong-Bo |e verfasserin |4 aut | |
700 | 1 | |a Jin, Jia-Yu |e verfasserin |4 aut | |
700 | 1 | |a Guo, Jie-Yu |e verfasserin |4 aut | |
700 | 1 | |a Ding, Qiu-Rong |e verfasserin |4 aut | |
700 | 1 | |a Meng, Dan |e verfasserin |4 aut | |
700 | 1 | |a Zhi, Xiu-Ling |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Acta pharmacologica Sinica |d 2000 |g 45(2024), 5 vom: 04. Apr., Seite 879-889 |w (DE-627)NLM111735181 |x 1745-7254 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2024 |g number:5 |g day:04 |g month:04 |g pages:879-889 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41401-023-01211-6 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 45 |j 2024 |e 5 |b 04 |c 04 |h 879-889 |